Bank of Montreal
OKUR

Bank of Montreal’s OnKure Therapeutics OKUR Stock Holding History

Bank of Montreal’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,062
Closed -$101K – 3998
2024
Q3 		$101K Sell
6,062
-7,012
-54% -$104K ﹤0.01% 3249
2024
Q2 		$213K Sell
13,074
-329
-2% -$5.58K ﹤0.01% 2962
2024
Q1 		$228K Buy
+13,403
New +$221K ﹤0.01% 2965
2023
Q1 		– Sell
-3,350
Closed -$80.4K – 4267
2022
Q4 		$80.4K Buy
+3,350
New +$88.8K ﹤0.01% 3427

Other funds holding OKUR

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bank of Montreal's OKUR Position: Q4 2024 in Review

Bank of Montreal sold out of OnKure Therapeutics (OKUR) in Q4 2024, closing a stake of 6,062 shares — an estimated $101K sold.

Bank of Montreal first reported a position in OKUR in Q4 2022 and held it in 4 quarters. The position peaked at $228K in Q1 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q4 2024.

  • Bank of Montreal reported no remaining OnKure Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 6,062 OnKure Therapeutics shares in Q4 2024, an estimated $101K.
  • Bank of Montreal first reported a position in OnKure Therapeutics in Q4 2022 and held it in 4 quarters.
  • Bank of Montreal's OnKure Therapeutics position peaked at $228K in Q1 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.